December 08, 2022CorporateUltimaster Drug Eluting Stent family (Terumo) first stent to receive the mention 1-month DAPT in the reimbursement conditions in France
December 06, 2022CorporateTerumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
December 02, 2022FinancialNotification Regarding Status of Acquisition of the Company's Own Shares (PDF 104.44 KB) (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation)
Terumo Corporation Tokyo Office Tokyo Opera City Tower 49F, 3-20-2 Nishi-Shinjuku, Shinjuku-ku Tokyo, 163-1450, Japan
Top
Top